| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/2009 | EP0938553B1 Dna encoding dp-75 and a process for its use |
| 08/05/2009 | EP0819004B1 Pharmaceutical composition containing proton pump inhibitors |
| 08/05/2009 | EP0813424B2 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/05/2009 | CN201283163Y Drug delivery system for infusion of radioactive ray sensitizer |
| 08/05/2009 | CN201283091Y Radioactive ray sensitizer inclusion body for injection and/or infusion |
| 08/05/2009 | CN101501194A Protection against and treatment of age related macular degeneration |
| 08/05/2009 | CN101501193A Methods and means for treating DNA repeat instability associated genetic disorders |
| 08/05/2009 | CN101501056A Aptamers that bind thrombin with high affinity |
| 08/05/2009 | CN101501053A 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors |
| 08/05/2009 | CN101501052A Large-particle cyclodextrin inclusion complexes and methods of preparing same |
| 08/05/2009 | CN101501051A Amides as sphingomyeline inhibitors |
| 08/05/2009 | CN101501049A Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 08/05/2009 | CN101501042A Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | CN101501041A Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 08/05/2009 | CN101501040A Amino-imidazolones and their use as a medicament for treating cognitive impairment, Alzheimer disease, neurodegeneration and dementia |
| 08/05/2009 | CN101501039A Pyrro[1,2-b]pyridazinone compounds |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101501036A Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | CN101501035A Pyrimidine derivative as P13K inhibitor and use thereof |
| 08/05/2009 | CN101501034A 1, 7-naphthyridine derivatives as p38 map kinase inhibitors |
| 08/05/2009 | CN101501032A Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 08/05/2009 | CN101501031A Oxazolidone derivatives as pr modulators |
| 08/05/2009 | CN101501030A Pyrimidine derivatives useful in the treatment of cancer |
| 08/05/2009 | CN101501028A 2-(heterocyclylbenzyl)-pyridazinonderivate |
| 08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| 08/05/2009 | CN101501025A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501024A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 08/05/2009 | CN101501022A Benzimidazole derivatives which are to be used as anatgonis for the CB1-receptor |
| 08/05/2009 | CN101501021A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501020A Nitrate esters of piperidines |
| 08/05/2009 | CN101501019A Short-acting benzodiazepine salts and their polymorphic forms |
| 08/05/2009 | CN101501018A Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 08/05/2009 | CN101501015A Use of coumarin derivatives in antifungal therapy |
| 08/05/2009 | CN101501009A CGRP receptor antagonists |
| 08/05/2009 | CN101501008A Arylpiperazine derivatives and uses thereof |
| 08/05/2009 | CN101501007A Quinazoline derivative |
| 08/05/2009 | CN101501005A Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| 08/05/2009 | CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators |
| 08/05/2009 | CN101501003A Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands |
| 08/05/2009 | CN101501002A Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2009 | CN101501000A Purification process of Montelukast and its amine salts |
| 08/05/2009 | CN101500998A Mono-and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 08/05/2009 | CN101500993A 2-aminocarbonylphenylamino-2-phenilacetamides as factor VIIa inhibitors useful as anticoagulants |
| 08/05/2009 | CN101500991A Lipoic acid derivatives |
| 08/05/2009 | CN101500654A Compositions for the treatment of chronic degenerative inflammatory conditions |
| 08/05/2009 | CN101500653A Treatment of gastrointestinal disorders with CGRP-antagonists |
| 08/05/2009 | CN101500613A A novel lactic acid formulation of MK-0457 useful for the treatment of cancer |
| 08/05/2009 | CN101500611A Combination of a cholinesterase inhibitor and a compound with 5-HT6 receptor affinity |
| 08/05/2009 | CN101500610A Anti-obesity agent and use thereof |
| 08/05/2009 | CN101500598A Cladribine regimen for treating multiple sclerosis |
| 08/05/2009 | CN101500594A Methods and compositions for treating ophthalmic conditions via modulation of megalin activity |
| 08/05/2009 | CN101500583A Drug delivery polymer with hydrochloride salt of clindamycin |
| 08/05/2009 | CN101500582A Use of escin |
| 08/05/2009 | CN101500581A Codon-optimized DNA molecules encoding the receptor binding domains of clostridium difficile toxins A and B, and methods of use thereof |
| 08/05/2009 | CN101500580A C-glycolipids with enhanced Th-1 profile |
| 08/05/2009 | CN101500579A Methods and compositions for inhibiting IMPDH isoform 1 |
| 08/05/2009 | CN101500578A Metered-dose and safety and compliance packaging for systemic anticancer therapy |
| 08/05/2009 | CN101500577A Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 08/05/2009 | CN101500576A Agents for preventing and treating disorders involving modulation of the RYR receptors |
| 08/05/2009 | CN101500575A Thienopyrimidines useful as modulators of ion channels |
| 08/05/2009 | CN101500574A Compounds and compositions as protein kinase inhbitors |
| 08/05/2009 | CN101500573A Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 08/05/2009 | CN101500572A Solid compositions comprising tadalafil and at least one carrier |
| 08/05/2009 | CN101500571A Stable lyophilized preparation |
| 08/05/2009 | CN101500570A Novel tape preparation |
| 08/05/2009 | CN101500569A HIF hydroxylase inhibitors for treatment of anemia of cancer |
| 08/05/2009 | CN101500568A Pharmaceutical formulations of pimavanserin |
| 08/05/2009 | CN101500567A Use of a P38 kinase inhibitor for treating psychiatric disorders |
| 08/05/2009 | CN101500566A Use of HPPD inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs |
| 08/05/2009 | CN101500565A Modulators of muscarinic receptors |
| 08/05/2009 | CN101500564A Prodrugs of benzoquinolizine-2-carboxylic acid |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500562A Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 08/05/2009 | CN101500561A Treatment of endocrine dysfunction using iron chelators |
| 08/05/2009 | CN101500560A Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 08/05/2009 | CN101500559A Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 08/05/2009 | CN101500558A Succinimide derivatives as ocular hypotensive agents |
| 08/05/2009 | CN101500557A Nitrofuran compounds for the treatment of cancer and angiogenesis |
| 08/05/2009 | CN101500556A Compositions containing zinc salts for coating medical articles |
| 08/05/2009 | CN101500555A Novel formulations comprising fenofibrate and a statin, and related methods of treatment |
| 08/05/2009 | CN101500554A Sulfonamide compound or salt thereof |
| 08/05/2009 | CN101500553A Compositions and methods for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with PPI |
| 08/05/2009 | CN101500552A Antiviral use of cationic surfactant |
| 08/05/2009 | CN101500551A Compositions containing chalcones and use thereof |
| 08/05/2009 | CN101500550A Compositions with enhanced elasticizing activity |
| 08/05/2009 | CN101500549A Casein complexes |
| 08/05/2009 | CN101500548A Polyconjugates for in vivo delivery of polynucleotides |
| 08/05/2009 | CN101500547A Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 08/05/2009 | CN101500546A Nanoparticle compositions |
| 08/05/2009 | CN101500545A Ibuprofen-containing liquid filled hard capsules |
| 08/05/2009 | CN101500542A Controlled-release formulations |
| 08/05/2009 | CN101500541A Process for production of spherical granule containing slightly water-soluble substance |
| 08/05/2009 | CN101500539A Enhanced stability phenylephrine liquid compositions |
| 08/05/2009 | CN101500535A Compositions with several hyaluronic acid fractions for cosmetic and medical uses |
| 08/05/2009 | CN101500534A Compositions comprising betulonic acid |
| 08/05/2009 | CN101500420A New polymeric materials and methods |
| 08/05/2009 | CN101500419A Compounds useful for treating HIV |
| 08/05/2009 | CN101500418A Method of inhibiting the transmission of influenza virus |
| 08/05/2009 | CN101500409A Improved tissue maintenance |